COVID-19 and systemic lupus erythematosus: a case series
- 25 May 2020
- journal article
- editorial
- Published by Elsevier in The Lancet Rheumatology
- Vol. 2 (8), e452-e454
- https://doi.org/10.1016/s2665-9913(20)30161-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New YorkNew England Journal of Medicine, 2020
- Response to: ‘Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’’ by Nikpouret alAnnals Of The Rheumatic Diseases, 2020
- Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquineAnnals Of The Rheumatic Diseases, 2020
- SARS-CoV-2 and viral sepsis: observations and hypothesesThe Lancet, 2020
- Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registriesThe Lancet Rheumatology, 2020
- Thoughts on COVID-19 and autoimmune diseasesLupus Science & Medicine®, 2020
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapiesAnnals Of The Rheumatic Diseases, 2020
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997